#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurofibroma Myelin oligodendrocyte glycoprotein antibody-associated disease Warm autoimmune haemolytic anaemia Soft tissue necrosis Microvillous inclusion disease Congenital ectodermal dysplasia Acute graft versus host disease in skin Sickle cell disease Arterial tortuosity syndrome Mucopolysaccharidosis III Follicular lymphoma stage III Ewing's sarcoma Pulmonary hypertension Epstein-Barr virus infection Acute lymphocytic leukaemia recurrent More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Treatment Aicardi-Goutieres syndrome Hereditary neuropathic amyloidosis – Treatment IgA nephropathy Mantle cell lymphoma refractory – Basic Information Mantle cell lymphoma stage IV – Basic Information Hairy cell leukaemia recurrent – Trials in Disease Indolent systemic mastocytosis – Diagnostics Glycogen storage disease type V Paroxysmal nocturnal haemoglobinuria – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mosunetuzumab SPY002 Terbinafine Alternaria Alternata (402) PICLIDENOSON GOLD SODIUM THIOSULFATE UDONITRECTAG METHYLPHENIDATE Simeticone Topotecan Epirubicin Hydrochloride Clioquinol Exemestane Betula Verrucosa (108) Pf-06480605 BI 456906 Phenylephrine Hydrochloride AGALSIDASE BETA Emicizumab Autologous Chondrocytes More therapies…

    Learn about Your Condition

    Metastatic gastric cancer Richter's syndrome Chronic disease Metastases to biliary tract Rosai-Dorfman syndrome Hepatoblastoma Systemic candida Head and neck cancer stage III Obesity PIK3CA-activated mutation Head and neck cancer stage IV Obsessive-compulsive disorder Thyroid cancer Endometrial cancer stage II Perinatal depression More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Diphenhydramine
    • Other Analgesics And Antipyretics
    • Axicabtagene Ciloleucel
    Austria France Germany Italy The Netherlands Portugal +1

  • Study of Asciminib Treatment for Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    Germany

  • Study on Carfilzomib and Ibrutinib for Patients with Waldenström’s Macroglobulinemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Waldenstrom’s macroglobulinaemia
    Investigated Drugs:
    • Carfilzomib
    • Ibrutinib
    Austria Germany Greece

  • Study on Midostaurin and Decitabine for Adults with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Who Are Unfit for Intensive Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Decitabine
    • Midostaurin
    Belgium The Netherlands

  • Study of Pioglitazone and Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia Patients After Stopping Treatment Attempts

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Pioglitazone
    France

  • Study of Bexmarilimab Combined with Standard Treatment for Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Bexmarilimab
    Finland
Previous Page
1 … 82 83 84 85 86 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!